study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MENT-GUT-AXIS_01,2017,randomized controlled trial,SMD,-0.2910,-0.4304,-0.1516,62,48,low,10.1016/j.neubiorev.2019.03.023,mental_health_journal,anxiety,Adults with anxiety concerns,None reported,9
MENT-GUT-AXIS_02,2018,randomized controlled trial,SMD,-0.3372,-0.4751,-0.1993,66,51,some concerns,10.1186/s12888-023-04963-x,mental_health_journal,anxiety,Adults with anxiety concerns,Mild GI discomfort,10
MENT-GUT-AXIS_03,2019,randomized controlled trial,SMD,-0.4256,-0.5637,-0.2875,70,54,mixed,10.3390/nu14091918,mental_health_journal,anxiety,Adults with anxiety concerns,Transient headache,11
